Charles River Laboratories International revenue and financials

CRL · NYSE · USD

Compare Charles River Laboratories International
$337.97Change from previous close: −0.83%Absolute change: −$2.84

Close · November 13, 2026

In the fiscal year ended December 2025, Charles River Laboratories International reported revenue of $4.02B (−0.85% year over year). The net loss was $144.34M.

Annual revenue · 2025: $4.02B
  1. $1.68B2016
  2. $1.86B2017
  3. $2.27B2018
  4. $2.62B2019
  5. $2.92B2020
  6. $3.54B2021
  7. $3.98B2022
  8. $4.13B2023
  9. $4.05B2024
  10. $4.02B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
−0.85%
2025 vs 2024
Net margin
-3.6%
2024: 0.5%

How Charles River Laboratories International is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue4,0154,0504,1293,9763,5402,9242,6212,2661,8581,681
Cost of revenue2,6112,6422,6002,5082,2031,8501,6561,423290277
Gross profit1,4051,4081,5291,4681,3371,074965843722658
Selling, general and administrative728724743656578523488436367343
Operating income25.2227617651590433351331288238
EBIT498546649666634439388342313273
EBITDA877870963969900674586504444400
Interest expense10712613759.373.986.460.963.829.827.7
Pre-tax income-99.593.1581623481447304282297223
Income tax42.767.810113081.981.850.054.517166.8
Net income-14422.2475486391364252226123155
Net income to common shareholders-14410.3475486391364252225123154
Basic EPS-2.910.209.279.577.777.355.174.722.603.29
Diluted EPS-2.910.209.229.487.607.205.074.622.543.23
Average shares (basic)49.651.451.250.850.349.648.747.947.547.0
Average shares (diluted)49.651.651.551.351.450.649.749.048.648.0

Companies in the group: same industry, similar size